{"type":"profile","id":"profile=medica2026.3080548","exhSeoId":"68oUwXNhT9KGKclhBmj9Lw","name":"Zeta Corporation","email":"info@zeta-corp.com","getInTouchEmail":"info@zeta-corp.com","profileAddress":{"address":["65, N. 1st Avenue, Suite 202c"],"city":"Arcadia, CA","zip":"91006","country":"USA","countryCode":"US"},"phone":{"phone":"+1 626 3552053"},"links":[{"id":"link=YATXy0WjQeq2Ft6FRaYxCg","type":"link","link":"https://zeta-corp.com","parentType":"profile","order":1,"visibleInLang":["en","de"]}],"media":[],"locations":[{"areaId":"03","area":"Hall 3","stand":"D35-7"}],"location":"Hall 3 / D35-7","locationIsVirtual":false,"events":[{"key":"medica2026","label":"MEDICA 2026"}],"eventIcons":[{"label":"MEDICA 2026","src":"https://www.medica.de/vis-content/event-medica2026/all-exh/Event-0mOSbpheSRej6t2ZLcI1AA.png"}],"eventMap":"https://iahapla02.messe-duesseldorf.de/en/2dexgroundV2/medica2026/3080548.svg","areaMap":"https://iahapla02.messe-duesseldorf.de/en/3dhallV2/medica2026/03/3080548.svg","areaId":"03","premium":false,"exhIsLead":false,"logoUploadedByPubimport":false,"tags":[{"id":"tag=medica2026.0","label":"Manufacturer","icon":"md md-tag-label md-tag-label-m"}],"xtags":[],"socialMedia":[{"title":"LinkedIn","link":"https://www.linkedin.com/company/zetacorporation","network":"linkedin","standardDomain":"https://www.linkedin.com/"}],"synonyms":[],"text":"<p>Zeta Corporation specializes in the development, manufacture, and distribution of high-quality IVD antibodies for immunohistochemistry (IHC) and anatomic pathology. Drawing on over 75 years of collective expertise, Zeta delivers highly sensitive, specific, and reproducible antibodies for tumor diagnosis and disease differentiation.</p><p><br></p><p>An ISO 13485:2016 certified and FDA-registered biomedical company, Zeta has recently achieved EU IVDR and MDSAP certification, further demonstrating its commitment to quality, regulatory compliance, and international standards.</p><p><br></p><p>Zeta's proprietary RAbMono™ rabbit monoclonal and MonoMAb™ monospecific monoclonal antibody lines utilize advanced hybridoma and recombinant technologies, supported by rigorous validation and quality control.</p><p><br></p><p>Its expanding portfolio includes innovative DUALstain™ antibody cocktails, enabling simultaneous visualization of two biomarkers on a single tissue section for enhanced diagnostic information.</p><p><br></p><p>Zeta serves laboratories worldwide, distributing its products directly in the United States and through trusted partners in more than 50 countries.</p>","pdfs":[{"id":"paper=QRMf6fPcTA6NGWg9xSm30g","type":"paper","title":"ZETA_E-Catalog_2026","source":"https://www.medica.de/vis-content/event-medica2026/exh-medica2026.3080548/MEDICA-2026-Zeta-Corporation-Paper-medica2026.3080548-17FmsZcHTSmbaUhqbV8tLw.pdf","parentType":"profile","fileName":"ZETA_E-Catalog_2026.pdf","order":1,"visibleInLang":["en","de"]},{"id":"paper=FlkkLNGhTlSyATVxWqBOMw","type":"paper","title":"Zeta_Double Stain Cocktails and Detection","source":"https://www.medica.de/vis-content/event-medica2026/exh-medica2026.3080548/MEDICA-2026-Zeta-Corporation-Paper-medica2026.3080548-3kDjp1CWTZGas9PZDvfT2A.pdf","parentType":"profile","fileName":"Zeta_Double Stain Cocktails and Detection-8-25_FINAL.pdf","order":2,"visibleInLang":["en","de"]},{"id":"paper=Q4lHc2pdSx2bnRfus3k3bA","type":"paper","title":"Zeta B_Cell_Clonality DualStain_Product_Focus","source":"https://www.medica.de/vis-content/event-medica2026/exh-medica2026.3080548/MEDICA-2026-Zeta-Corporation-Paper-medica2026.3080548-X1QHrY3VTu2j0Swd8rHLhg.pdf","parentType":"profile","fileName":"Zeta B_Cell_Clonality DualStain_Product_Focus_11-26-FINAL.pdf","order":3,"visibleInLang":["en","de"]},{"id":"paper=E9zS3t3rQJ2MrJwx8cJ18A","type":"paper","title":"ZETA_Hereditary Breast Cancer_Product_Focus","source":"https://www.medica.de/vis-content/event-medica2026/exh-medica2026.3080548/MEDICA-2026-Zeta-Corporation-Paper-medica2026.3080548-2wZFh8muTf6uHJrJcCRmNg.pdf","parentType":"profile","fileName":"ZETA_Hereditary Breast Cancer_Product_Focus-10-26.pdf","order":4,"visibleInLang":["en","de"]},{"id":"paper=4qhzdPbCTaWVZPVmD0435A","type":"paper","title":"ZETA_Childhood_Cancer_Product_Focus","source":"https://www.medica.de/vis-content/event-medica2026/exh-medica2026.3080548/MEDICA-2026-Zeta-Corporation-Paper-medica2026.3080548-5cUNg2U6SliAx7uZCSEw0Q.pdf","parentType":"profile","fileName":"ZETA_Childhood_Cancer_Product_Focus_2-25_C.pdf","order":5,"visibleInLang":["en","de"]},{"id":"paper=8QE1ULiUTiKlcKYbMpXQRg","type":"paper","title":"Zeta_Sarcoma and Bone Cancer_Product Focus","source":"https://www.medica.de/vis-content/event-medica2026/exh-medica2026.3080548/MEDICA-2026-Zeta-Corporation-Paper-medica2026.3080548-xY6CGTaUQxytUALEC1vqkg.pdf","parentType":"profile","fileName":"ZETA_Sarcoma and Bone Cancer_Product_Focus_UPDATED_7-26.pdf","order":6,"visibleInLang":["en","de"]},{"id":"paper=vTGlhwXyQ8GplpQEI7tbpQ","type":"paper","title":"ZETA_TRPS1_InFocus","source":"https://www.medica.de/vis-content/event-medica2026/exh-medica2026.3080548/MEDICA-2026-Zeta-Corporation-Paper-medica2026.3080548-fA3hQFf5Q5uvvfXLJMMZ2g.pdf","parentType":"profile","fileName":"ZETA_TRPS1_InFocus_SellSheet.pdf","order":7,"visibleInLang":["en","de"]},{"id":"paper=mAwCC9HEQlWxBPlJnAcxNA","type":"paper","title":"Zeta Cancer Survivor_Product_Focus","source":"https://www.medica.de/vis-content/event-medica2026/exh-medica2026.3080548/MEDICA-2026-Zeta-Corporation-Paper-medica2026.3080548-6WIrMrqoQ4eC1PgF5aALLw.pdf","parentType":"profile","fileName":"Zeta Cancer Survivor_Product_Focus_6-26-REV1.pdf","order":8,"visibleInLang":["en","de"]}],"tol":[],"categories":[],"write":false,"lastModified":"2026-11-05T21:11:38Z","tagsAreEditable":false,"xtagsAreEditable":false,"isGetInTouchAllowed":false}